Early stage biotechnology company
Deka Biosciences has raised $29.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2023.
Deka Biosciences's investors include Lumira Ventures, MPM Capital, Alexandria Venture Investments, Echo Investment Capital, Leaps by Bayer.
Deka Biosciences is headquartered in Germantown, United States.
Early stage biotechnology company
Deka Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Deka Biosciences — Funding & Investors." VCBacked, December 8, 2023, https://www.vcbacked.co/company/deka-biosciences. Accessed September 29, 2026.
VCBacked. (2023). Deka Biosciences — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/deka-biosciences
{{cite web |title=Deka Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/deka-biosciences |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated